Abstract
The purpose of this study was to identify the effect of oral zinc supplementation in patients with type 1 diabetes (T1DM) on metabolic control and zinc blood concentrations. The sample consisted of 20 patients with T1DM and a control group (n=17). Metabolic control was evaluated by glycemia at fast, 24 h glycosuria, and HbA1c. Zinc concentrations were measured in plasma and erythrocytes. After the first collection of biological material, oral zinc supplementation was initiated and continued for 4 mo in T1MD patients (T1). Daily dosages were established based on Dietary Recommended Intakes (DRIs), considering zinc intake based on data from other studies previously performed with this population. All analyses were repeated after supplementation (T2). Metabolic control was unsatisfactory, with an HbA1c increase at T2. There was no difference in zinc concentrations in plasma and erythrocytes between patients with T1DM and control. Zinc concentrations in plasma were within the normal range in T1MD before and after supplementation and the control. Zinc concentrations in erythrocyte presented lower than normal values for all groups. A zinc increase in erythrocyte after supplementation was observed in T1DM patients, although without statistical significance. More studies are needed to confirm oral zinc supplementation as nutritional management in diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. B. Chausmer, Zinc, insulin and diabetes, J. Am. Coll. Nutr. 17, 109–115 (1998).
M. J. Salgueiro, N. Krebs, M. B. Zubillaga, et al. Is there a need of zinc supplementation in diabetes mellitus patients? Biol. Trace Element Res. 81, 215–228 (2001).
H. H. Sandstead and G. E. Norman, Is zinc a nutriture problem in persons with diabetes mellitus? Am. J. Clin. Nutr. 66(3), 681–682 (1997).
L. F. C. Pedrosa and S. M. F. Cozzolino, Alleraço ~es metabólicas e funcionais do zinco em diabetes mellitus, Arq. Bras. Endocrinol. Metab. 42, 422–430 (1998).
W. K. Canfield, K. M. Hambidge, and L. K. Johnson, Zinc nutriture in type I diabetes mellitus: relationship to growth measures and metabolic control, J. Pedriatr Gastroenterol. Nutr. 3, 577–584 (1984).
K. C. M. Sena and L. F. C. Pedrosa, Efeitos da suplementação com zinco sobre o crescimento, sistema imunológico e diabetes: Uma revisão, Rev. Nutr. 18(2), (2005), in press.
J. J. Cunningham, A. Fu, L. Mearkle, et al., Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and effect of hight-dose zinc supplementation. Metabolism 43, 1558–1562 (1994).
P. Faure, P. Y. Benhamou, A. Perard, et al., Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation, Eur. J. Clin. Nutr. 49, 282–288 (1995).
K. C. M. Sena, R. F. Arrais, T. N. S. Brito, et al., Efeito da suplementação com zinco sobre a zincúria em pacientes com diabetes tipo 1. Arq Bras. Endocrinol. Metab. 47(5), 572–577 (2003).
J. M. Tanner and R. H. Whitehouse, Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty, Arch. Dis. Child. 62, 57–62 (1976).
National Academy of Science, Food and Nutrition Board, Institute of Medicine (USA), Dietary Reference Intakes (DRI) for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Cooper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc, National Academy of Science, Washington, DC (2001)
M. P. Rodriguez, A. Nazariano, V. Demczylo, et al., A simpler method for the determination of zinc human plasma levels by flame atomic absorption spectrophotometry, Atomic Spectrosc. 10(2), 68–70 (1989).
R. C. Whitehouse, A. S. Prasad, P. I. Rabbani, et al., Zinc in plasma neutrophils, lymphocytes and erytrocytes as determined by flameless atomic absorption spectrophotometry, Clin. Chem., 28, 475–480 (1982).
R. S. Gibson, Assessment of trace-elements status, in Principles of Nutritional Assessment, R. S. Gibson, ed., Oxford University Press, Oxford, pp. 542–553 (1990).
C. B. Niewoehner, J. I. Allen, M. Boosalis, et al., Role of zinc supplementation in type II diabetes mellitus, Am. J. Med. 81, 63–68 (1986).
C. Ruiz, A. Alegria, R. Barbera, et al., Selenium, zinc and cooper in plasma of patients with type 1 diabetes mellitus in different metabolic control states, J. Trace Elements Med. Biol. 12, 91–95 (1998).
L. Kennedy, T. D. Mehl, E. Elder, et al., Noenzymatic glycosylation of serum and plasma proteins, Diabetes 31, 52–56 (1982).
L. F. C. Pedrosa, S. R. G. Ferreira, P. R. Cesarini, et al., Influence of glycemic control on zinc urinary excretion in patients with type 1 diabetes, Diabetes Care 22, 362–363 (1999).
J. D. Kruse-Jarres and M. Rukgauer, Trace elements in diabetes mellitus. Pecularities and clinical validity of determinations in blood cells, J. Trace Elements Med. Biol. 14, 21–27 (2000).
D. Vitoux, J. Arnaud, and P. Chappuis, Are cooper, zinc, selenium inerithrocytes valuable biological indexes of nutrition and pathology? J. Trace Elements Med. Biol. 13, 113–128 (1999).
L. F. C. Pedrosa, A. Spínola-Castro, M. Matsumoto, et al., Evaluation of zinc in children with type 1 diabetes mellitus, in Trace Elements in Man and Animals, A. M. Roussel, R. A. Anderson, and A. E. Favier, eds., Kluwer Academic/Plenum, New York, pp. 511–513 (2000).
R. D. Rohn, P. Pleban, and L. L. Jenkins, Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM, Clin. Chim. Acta 215, 21–28 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Sena, K.C.M., de Araújo, A.D.M., Santos, M.M.d. et al. Effects of zinc supplementation in patients with type 1 diabetes. Biol Trace Elem Res 105, 1–9 (2005). https://doi.org/10.1385/BTER:105:1-3:001
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:105:1-3:001